Tumor regression caused by endotoxins and mycobacterial fractions.

PubWeight™: 1.17‹?› | Rank: Top 10%

🔗 View Article (PMID 173865)

Published in J Natl Cancer Inst on November 01, 1975

Authors

E E Ribi, D L Granger, K C Milner, S M Strain

Articles citing this

Granuloma formation in lungs of mice after intravenous administration of emulsified trehalose-6,6'-dimycolate (cord factor): reaction intensity depends on size distribution of the oil droplets. Infect Immun (1977) 1.32

High-level induction of gamma interferon with various mitogens in mice pretreated with Propionibacterium acnes. Infect Immun (1982) 1.14

Failure of trehalose-6,6'-dimycolate (P3 or cord factor) to enhance endotoxin lethality in mice. Infect Immun (1976) 1.04

Immunology of bronchial carcinoma. Thorax (1976) 0.98

Plasma-dependent chemotaxis of macrophages toward BCG cell walls and the mycobacterial glycolipid P3. Infect Immun (1977) 0.86

Abrogation of suppression of delayed hypersensitivity induced by Candida albicans-derived mannan by treatment with monophosphoryl lipid A. Infect Immun (1993) 0.86

Microorganisms and cancer: quest for a therapy. J Bacteriol (2003) 0.86

Differences in tumour necrosis factor productive ability among rodents. Br J Cancer (1984) 0.83

Antitumor activity of mycobacterial glycolipid A1. Infect Immun (1978) 0.78

The role of mycobacterial cell wall nucleic acid complex in the treatment of bacillus Calmette-Guérin failures for non-muscle-invasive bladder cancer. Ther Adv Urol (2016) 0.75

Effect of sulfolipid I on trehalose-6,6'-dimycolate (cord factor) toxicity and antitumor activity. Infect Immun (1979) 0.75

Lipid A structural modifications in extreme conditions and identification of unique modifying enzymes to define the Toll-like receptor 4 structure-activity relationship. Biochim Biophys Acta (2017) 0.75

Articles by these authors

Virulence of Cryptococcus neoformans. Regulation of capsule synthesis by carbon dioxide. J Clin Invest (1985) 3.98

Reaction of endotoxin and surfactants. I. Physical and biological properties of endotoxin treated with sodium deoxycholate. J Bacteriol (1966) 2.86

Nitric oxide in Tanzanian children with malaria: inverse relationship between malaria severity and nitric oxide production/nitric oxide synthase type 2 expression. J Exp Med (1996) 2.75

Sites of inhibition of mitochondrial electron transport in macrophage-injured neoplastic cells. J Cell Biol (1982) 2.54

The role of nitric oxide in the pathogenesis of spontaneous murine autoimmune disease: increased nitric oxide production and nitric oxide synthase expression in MRL-lpr/lpr mice, and reduction of spontaneous glomerulonephritis and arthritis by orally administered NG-monomethyl-L-arginine. J Exp Med (1994) 2.50

Preparation and properties of a national reference endotoxin. J Clin Microbiol (1976) 2.30

Inhibition of Cryptococcus neoformans replication by nitrogen oxides supports the role of these molecules as effectors of macrophage-mediated cytostasis. Infect Immun (1991) 2.23

Physical aspects of reversible inactivation of endotoxin. Ann N Y Acad Sci (1966) 2.21

Bioassay of endotoxin: correlation between pyrogenicity for rabbits and lethality for chick embryos. J Infect Dis (1966) 2.15

Macrophage-mediated fungistasis in vitro: requirements for intracellular and extracellular cytotoxicity. J Immunol (1986) 2.06

Nitric oxide produced during murine listeriosis is protective. Infect Immun (1994) 1.93

Human alveolar and peritoneal macrophages mediate fungistasis independently of L-arginine oxidation to nitrite or nitrate. Am Rev Respir Dis (1990) 1.90

Effect of in vivo inhibition of nitric oxide production in murine leishmaniasis. J Immunol (1993) 1.88

Effects of antifungal agents and gamma interferon on macrophage cytotoxicity for fungi and tumor cells. J Infect Dis (1987) 1.85

Separation of the mixture of trehalose 6,6'-dimycolates comprising the mycobacterial glycolipid fraction, "P3". Biochem Biophys Res Commun (1977) 1.82

Injury of neoplastic cells by murine macrophages leads to inhibition of mitochondrial respiration. J Clin Invest (1980) 1.82

Biologically active components from mycobacterial cell walls. I. Isolation and composition of cell wall skeleton and component P3. J Natl Cancer Inst (1974) 1.82

Factors influencing protection against experimental tuberculosis in mice by heat-stable cell wall vaccines. J Bacteriol (1966) 1.75

Frequency of occurrence of native hapten among enterobacterial species. J Bacteriol (1966) 1.66

Neutralization of gamma interferon and tumor necrosis factor alpha blocks in vivo synthesis of nitrogen oxides from L-arginine and protection against Francisella tularensis infection in Mycobacterium bovis BCG-treated mice. Infect Immun (1993) 1.65

Chemical, biological, and structural properties of stable Proteus L forms and their parent bacteria. J Bacteriol (1967) 1.55

Alteration of physical, chemical, and biological properties of endotoxin by treatment with mild alkali. J Bacteriol (1969) 1.48

Location of polar substituents and fatty acyl chains on lipid A precursors from a 3-deoxy-D-manno-octulosonic acid-deficient mutant of Salmonella typhimurium. Studies by 1H, 13C, and 31P nuclear magnetic resonance. J Biol Chem (1985) 1.46

Enhancement of endotoxic shock by N-acetylmuramyl-L-alanyl-(L-seryl)-D-isoglutamine (muramyl dipeptide). Cancer Res (1979) 1.44

Structure and metal-binding properties of lipopolysaccharides from heptoseless mutants of Escherichia coli studied by 13C and 31P nuclear magnetic resonance. J Biol Chem (1983) 1.44

Mitochondrial iron loss from leukemia cells injured by macrophages. A possible mechanism for electron transport chain defects. J Immunol (1988) 1.41

Biological and chemical characterization of toxic substances from Candida albicans. Infect Immun (1972) 1.41

Biologically active components from mycobacterial cell walls. II. Suppression and regression of strain-2 guinea pig hepatoma. J Natl Cancer Inst (1974) 1.38

Characterization of lipopolysaccharide from a heptoseless mutant of Escherichia coli by carbon 13 nuclear magnetic resonance. J Biol Chem (1983) 1.37

Migration inhibitory factor and type II interferon in the circulation of mice sensitized with mycobacterial components. J Immunol (1975) 1.33

Tumor suppression by cell walls of mycobacterium bovis attached to oil droplets. J Natl Cancer Inst (1972) 1.32

Physical structure of a native protoplasmic polysaccharide from Escherichia coli. J Immunol (1967) 1.32

Delayed hypersensitivity and granulomatous response after immunization with protein antigens associated with a mycobacterial glycolipid and oil droplets. J Immunol (1976) 1.31

Hybrid formation between bacterial endotoxins. J Exp Med (1967) 1.26

Growth inhibition of Cryptococcus neoformans by human alveolar macrophages. Am Rev Respir Dis (1987) 1.20

Cerebrospinal fluid macrophage response to experimental cryptococcal meningitis: relationship between in vivo and in vitro measurements of cytotoxicity. Infect Immun (1988) 1.19

Early-phase endotoxin tolerance: induction by a detoxified lipid A derivative, monophosphoryl lipid A. Infect Immun (1986) 1.18

Macrophage-mediated fungistasis: requirement for a macromolecular component in serum. J Immunol (1986) 1.12

Modification of selected host-reactive properties of endotoxin by treatment with sodium deoxycholate. J Bacteriol (1968) 1.12

Lethality for mice and chick embryos, pyrogenicity in rabbits and ability to gelate lysate from amoebocytes of Limulus polyphemus by lipopolysaccharides from Bacteroides, Fusobacterium and Veillonella. Acta Pathol Microbiol Scand B (1977) 1.12

A promoter polymorphism in the gene encoding interleukin-12 p40 (IL12B) is associated with mortality from cerebral malaria and with reduced nitric oxide production. Genes Immun (2002) 1.07

Infectious arthritis due to Propionibacterium acnes in a prosthetic joint. Clin Infect Dis (1994) 1.06

Physicochemical and biological properties of sonically treated Vi antigen. J Bacteriol (1967) 1.06

Mycobacterial cell wall components in tumor suppression and regression. Natl Cancer Inst Monogr (1973) 1.04

Induction of resistance to tuberculosis in mice with defined components of mycobacteria and with some unrelated materials. Immunology (1982) 0.98

Pharmacology of systemically administered domoic acid in mice. Can J Physiol Pharmacol (1991) 0.98

Nitric oxide synthase type 2 promoter polymorphisms, nitric oxide production, and disease severity in Tanzanian children with malaria. J Infect Dis (1999) 0.98

Comparative behavioural toxicity of domoic acid and kainic acid in neonatal rats. Neurotoxicol Teratol (2001) 0.98

Structure and biological activities of acapsular Cryptococcus neoformans 602 complemented with the CAP64 gene. Infect Immun (1997) 0.97

Toxic and immunological differences among lipopolysaccharides from Thiobacillus ferrooxidans grown autotrophically and heterotrophically. Can J Microbiol (1973) 0.96

Cryptococcus neoformans fails to induce nitric oxide synthase in primed murine macrophage-like cells. Infect Immun (1995) 0.95

Nitric oxide, malaria, and anemia: inverse relationship between nitric oxide production and hemoglobin concentration in asymptomatic, malaria-exposed children. Am J Trop Med Hyg (1999) 0.95

Patterns of tolerance to endotoxin. J Infect Dis (1973) 0.95

Cutaneous granulomatous response to BCG cell walls with reference to cancer immunotherapy. Infect Immun (1976) 0.94

Noncardiogenic pulmonary edema during vivax malaria. Clin Infect Dis (1999) 0.93

Bartonella henselae: etiology of pulmonary nodules in a patient with depressed cell-mediated immunity. Clin Infect Dis (1995) 0.92

Opsonic activity of cerebrospinal fluid in experimental cryptococcal meningitis. Infect Immun (1990) 0.91

Reaction of endotoxin and surfactants. II. Immunologic properties of endotoxins treated with sodium deoxycholate. J Immunol (1968) 0.91

Effects of age and parasitemia on nitric oxide production/leukocyte nitric oxide synthase type 2 expression in asymptomatic, malaria-exposed children. Am J Trop Med Hyg (1999) 0.90

Human immunodeficiency virus (HIV)-infected human blood monocytes and peritoneal macrophages have reduced anticryptococcal activity whereas HIV-infected alveolar macrophages retain normal activity. J Infect Dis (1994) 0.87

Immunotherapy with nonviable microbial components. Ann N Y Acad Sci (1976) 0.86

Reaction of endotoxin and surfactants. 3. Effect of sodium lauryl sulfate on the structure and pyrogenicity of endotoxin. Can J Microbiol (1968) 0.85

Efficacy of immune therapy in early experimental Naegleria fowleri meningitis. Infect Immun (1987) 0.85

Novel Salmonella enterica serovar Typhimurium protein that is indispensable for virulence and intracellular replication. Infect Immun (2001) 0.84

Nitrate levels in malaria. Trans R Soc Trop Med Hyg (1997) 0.84

Endotoxin-altering activity in serum of developing chicken embryo: lack of correlation with embryonic susceptibility to injected endotoxin. Infect Immun (1973) 0.82

N omega -monomethyl-L-arginine inhibits nitric oxide production in murine cardiac allografts but does not affect graft rejection. Biochim Biophys Acta (1994) 0.80

New test for endotoxin potency based upon histamine sensitization in mice. Infect Immun (1977) 0.80

Inhibition of pulmonary granuloma formation in mice by treatment with Mycobacterial protoplasm and immuno-suppressants and its relation to protection against aerosol infection with virulent Mycobacterium tuberculosis. Zentralbl Bakteriol Mikrobiol Hyg A (1981) 0.80

Synergism between NMDA and domoic acid in a murine model of behavioural neurotoxicity. Neurotoxicology (1998) 0.79

Biologically active components from mycobacterial cell walls. III. Production of experimental allergic encephalomyelitis in guinea-pigs. Immunology (1975) 0.79

Aberrant oxygen metabolism in neoplastic cells injured by cytotoxic macrophages. Adv Exp Med Biol (1985) 0.79

Selective reduction in domoic acid toxicity in vivo by a novel non-N-methyl-D-aspartate receptor antagonist. Can J Physiol Pharmacol (1996) 0.78

Activated macrophage mediated cytotoxicity for transformed target cells. Adv Exp Med Biol (1982) 0.78

Selective detection of 3-deoxymannooctulosonic acid in intact lipopolysaccharides by spin-echo 13C NMR. J Biol Chem (1985) 0.77

Biology of the mycobacterioses. Structure and biological functions of mycobacteria. Ann N Y Acad Sci (1968) 0.77

Specific and nonspecific stimulation of resistance in mice aganist infection with Mycobacterium tuberculosis H37Rv. Pneumonologie (1970) 0.76

Induction of resistance to tuberculosis in mice with defined components of Mycobacteria and with some unrelated materials. Zentralbl Bakteriol Mikrobiol Hyg A (1982) 0.76

Occult endotoxin in bacterial protoplasm. J Bacteriol (1969) 0.75

Determination of heptose in endotoxins. J Bacteriol (1966) 0.75

Marihuana: identification of cannabinoids by centrifugal chromatography. Science (1971) 0.75

Von Willebrand's disease in Ireland. Ir Med J (1982) 0.75

Comparison of oral and tympanic temperatures in a Veterans Administration outpatient clinic. Am J Med Sci (1999) 0.75

Secondary syphilis masquerading as AIDS in a young gay male. N C Med J (1984) 0.75

Morphine differentially affects domoic acid and kainic acid toxicity in vivo. Neuroreport (1992) 0.75

Purification of 9 -tetrahydrocannabinol, an active constituent of marihuana, by accelerated microparticulate gel chromatography. Prep Biochem (1973) 0.75

Pressure accelerated chromatography through microparticulate silica columns packed by centrifugation. J Chromatogr Sci (1972) 0.75

Solubility of endotoxin and stability of its biological activity in organic liquids. Biotechnol Bioeng (1969) 0.75